Bitcoin's Record Break? (ad) |
Bitcoin has surged past $70,000. Are you prepared for what's next? Our free guide, "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024," is essential for staying ahead in the fast-evolving crypto market. It's crafted for both beginners and seasoned investors. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Click here to download your free report and start leading in the crypto race. |
|
Today's Top Stories | Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore | Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024 | My friend, the most controversial CEO in America, has a secret (Stansberry Research) | Unity Software's Mixed Q1, But Long-Term Outlook Remains Positive | British economy rebounds strongly in first quarter of the year, ending 'technical recession' | JFrog Stock Gets Punished for Solid Results: Buy the Dip | Stock market today: Wall Street coasts toward the close of another winning week | Buy Friday, Sell Monday, No Exceptions (WealthPress) | Will the Surge in GameStop Stock Spark a New Meme Craze? | European companies are less upbeat about China's vast market as its economy slows | 3 Stocks Nancy Pelosi Has Been Buying | Spending on home renovations slows, but high remodeling costs mean little relief in sight for buyers |
You missed the class - here's your second chance (ad) |
It's time to start your Weekend Side Hustle
Right now, some of the HARDEST working folks are getting destroyed by inflation.
And that's left folks looking anywhere they can to generate extra income to cover the bills.
It's almost impossible to keep up with the ever rising costs of living anymore…
Click here and I'll give you the details. |
|
Apple Inc. (AAPL) Amazon.com, Inc. (AMZN) Barker Minerals Ltd (BML) - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
Meta Platforms, Inc. (META) - insider Jennifer Newstead sold 576 shares of the company's stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $466.33, for a total transaction of $268,606.08. Following the completion of the sale, the insider now directly owns 36,067 shares in the company, valued at $16,819,124.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
- (5/10) Meta Platforms, Inc. (NASDAQ:META) Insider Jennifer Newstead Sells 576 Shares (insidertrades.com)
- (5/10) The 3 Most Undervalued Retirement Stocks to Buy in May 2024 (investorplace.com)
- (5/10) 1 Member of Congress Has Been Loading Up on This Artificial Intelligence (AI) Stock, and I Am, Too (fool.com)
- (5/10) The Smartest Dividend Stocks to Buy With Under $1,000 Right Now (fool.com)
- (5/10) Insider Sale: Jennifer Newstead Sells Shares of Meta Platforms Inc (META) (finance.yahoo.com)
- (5/10) Australia Calls For Inquiry Into Meta's Facebook, Elon Musk's X, TikTok To 'Make These Platforms Accountable For Their Decisions' (msn.com)
- (5/9) Australia targets social media with parliamentary probe (finance.yahoo.com)
- (5/9) Meta Platforms Stock (NASDAQ:META): Will Its Colossal Gains Continue or Reverse? (finance.yahoo.com)
- (5/9) Australia targets social media with parliamentary probe (reuters.com)
- (5/9) GDS Wealth Management Has $6.04 Million Stock Holdings in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
Microsoft Co. (MSFT) - Array Technologies (NASDAQ:ARRY) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $20.00 price target on the stock. This represents a 57.1% upside from the current price of $12.73.
- Bumble (NASDAQ:BMBL) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $14.00 price target on the stock. This represents a 24.0% upside from the current price of $11.29.
- Dutch Bros (NYSE:BROS) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock, up previously from $33.00. This represents a 29.4% upside from the current price of $35.55.
- Cheesecake Factory (NASDAQ:CAKE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $47.00 price target on the stock, up previously from $38.00. This represents a 26.3% upside from the current price of $37.20.
- Dominion Energy (NYSE:D) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $54.00 price target on the stock, up previously from $43.00. This represents a 1.4% upside from the current price of $53.26.
- HBT Financial (NASDAQ:HBT) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating. They now have a $23.00 price target on the stock. This represents a 17.7% upside from the current price of $19.54.
- Lear (NYSE:LEA) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $160.00 price target on the stock, up previously from $150.00. This represents a 23.2% upside from the current price of $129.85.
- 3M (NYSE:MMM) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $115.00 price target on the stock, up previously from $91.13. This represents a 16.1% upside from the current price of $99.01.
- Novavax (NASDAQ:NVAX) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.The current price is $9.46.
- Roblox (NYSE:RBLX) was upgraded by analysts at Moffett Nathanson from a "sell" rating to a "neutral" rating. They now have a $26.00 price target on the stock. This represents a 18.1% downside from the current price of $31.76.
- Relay Therapeutics (NASDAQ:RLAY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $15.00 price target on the stock. This represents a 140.4% upside from the current price of $6.24.
- Squarespace (NYSE:SQSP) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $50.00 price target on the stock, up previously from $34.00. This represents a 31.3% upside from the current price of $38.09.
- TPG (NASDAQ:TPG) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $52.00 price target on the stock, up previously from $43.00. This represents a 19.7% upside from the current price of $43.43.
- Tower Semiconductor (NASDAQ:TSEM) was upgraded by analysts at Susquehanna from a "neutral" rating to a "positive" rating. They now have a $55.00 price target on the stock, up previously from $36.00. This represents a 51.2% upside from the current price of $36.38.
- Warner Bros. Discovery (NASDAQ:WBD) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $11.00 price target on the stock. This represents a 34.5% upside from the current price of $8.18.
- View today's most recent analysts' upgrades at MarketBeat.com
While traders were studying charts, I was placing THIS trade (ad) |
Let me show you an example of how my $0.25 Cent Trades could work with an example from back in January this year, okay?
Now if you were looking at the charts…
The S&P 500 was officially out of the bear market and roaring higher…
By mid-January we were at new highs…
And folks were left guessing if the breakout would continue or if we would make a natural pullback.
Click now to see for yourself what $0.25 Cent Trades is all about |
|
- Baxter International (NYSE:BAX) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $40.00 price target on the stock. This represents a 12.5% upside from the current price of $35.56.
- Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $39.00 price target on the stock. This represents a 22.7% upside from the current price of $31.79.
- Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $31.79.
- Cerence (NASDAQ:CRNC) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $6.50 price target on the stock, down previously from $25.00. This represents a 18.6% upside from the current price of $5.48.
- Ginkgo Bioworks (NYSE:DNA) was downgraded by analysts at William Blair from a "market perform" rating to an "underperform" rating.The current price is $0.76.
- EPAM Systems (NYSE:EPAM) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $245.00 price target on the stock, down previously from $300.00. This represents a 31.6% upside from the current price of $186.14.
- Evolv Technologies (NASDAQ:EVLV) was downgraded by analysts at Lake Street Capital from a "buy" rating to a "hold" rating. They now have a $3.50 price target on the stock, down previously from $6.00. This represents a 45.8% upside from the current price of $2.40.
- Globant (NYSE:GLOB) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $200.00 price target on the stock, down previously from $230.00. This represents a 15.1% upside from the current price of $173.69.
- Light & Wonder (NASDAQ:LNW) was downgraded by analysts at Susquehanna from a "positive" rating to a "neutral" rating. They now have a $95.00 price target on the stock, down previously from $111.00. This represents a 4.2% upside from the current price of $91.17.
- MacroGenics (NASDAQ:MGNX) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.The current price is $3.51.
- MacroGenics (NASDAQ:MGNX) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $7.00 price target on the stock, down previously from $29.00. This represents a 99.4% upside from the current price of $3.51.
- MacroGenics (NASDAQ:MGNX) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $8.00 price target on the stock, down previously from $24.00. This represents a 127.9% upside from the current price of $3.51.
- Progyny (NASDAQ:PGNY) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $25.80.
- Planet Fitness (NYSE:PLNT) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $70.00 price target on the stock, down previously from $80.00. This represents a 9.4% upside from the current price of $64.00.
- PennantPark Investment (NASDAQ:PNNT) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $7.25.
- RAPT Therapeutics (NASDAQ:RAPT) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $4.00 price target on the stock, down previously from $13.00. This represents a 10.1% downside from the current price of $4.45.
- RAPT Therapeutics (NASDAQ:RAPT) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $4.45.
- Ready Capital (NYSE:RC) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.The current price is $8.35.
- Safehold (NYSE:SAFE) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, down previously from $22.00. This represents a 3.7% upside from the current price of $19.28.
- TELUS International (Cda) (NYSE:TIXT) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $10.00 price target on the stock, down previously from $13.00. This represents a 61.8% upside from the current price of $6.18.
- Vital Farms (NASDAQ:VITL) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $40.00 price target on the stock, up previously from $30.00. This represents a 8.3% upside from the current price of $36.93.
- Vista Outdoor (NYSE:VSTO) was downgraded by analysts at Lake Street Capital from a "buy" rating to a "hold" rating. They now have a $37.00 price target on the stock, up previously from $33.00. This represents a 5.1% upside from the current price of $35.19.
- View today's most recent analysts' downgrades at MarketBeat.com
How to build the ultimate dividend portfolio (ad) |
There's a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps?
PLUS: You'll get the names and tickers of the Best Dividend Stocks for FREE…
This way, by the time you finish the workshop you'll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.
Click here and I'll show you how to build the ultimate dividend portfolio. |
|
- Apogee Therapeutics (NASDAQ:APGE) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $80.00 price target on the stock. This represents a 55.3% upside from the current price of $51.50.
- Aquestive Therapeutics (NASDAQ:AQST) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 164.9% upside from the current price of $3.02.
- Enfusion (NYSE:ENFN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $11.00 price target on the stock. This represents a 20.7% upside from the current price of $9.11.
- Ferrari (NYSE:RACE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $403.00 price target on the stock. This represents a 0.0% downside from the current price of $403.18.
- Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $72.00 price target on the stock. This represents a 66.7% upside from the current price of $43.20.
- Solventum (NYSE:SOLV) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $70.00 price target on the stock. This represents a 10.1% upside from the current price of $63.58.
- Sow Good (OTC:SOWG) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $15.00 price target on the stock. This represents a 49.7% upside from the current price of $10.02.
- Sow Good (OTC:SOWG) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $20.00 price target on the stock. This represents a 99.6% upside from the current price of $10.02.
- Sow Good (OTCMKTS:SOWG) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $15.00 price target on the stock. This represents a 49.7% upside from the current price of $10.02.
- View today's most recent analysts' new coverage at MarketBeat.com
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: Biden out June 13; Kamala won't replace him? |
|
No comments:
Post a Comment